2021
DOI: 10.1007/s12664-020-01134-8
|View full text |Cite
|
Sign up to set email alerts
|

Serum C-reactive protein and neutrophil-to-lymphocyte ratio as predictors of survival in cirrhotic patients with systemic inflammatory response syndrome and bacterial infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“… Study Liver disease No. of patients Markers measured Outcome assessed Significance Vijayalekshmi, et al 54 Severe alcoholic hepatitis 50 Plasma VWF antigen 3-month mortality adjusted HR: 1.002 (95% CI: 1- 1.004) Tiwari, et al 55 Severe alcoholic hepatitis 34 Plasma VWF collagen binding activity In–hospital mortality (hospital stay: 6 days, median) AUC: 0.72 (95% CI: 0.54-0.89) Prasanna, et al 36 ACLF (as defined by APASL criteria) 50 Plasma VWF collagen binding activity In-hospital composite poor outcome a (hospital stay: 6 days, median) AUC: 0.68 (95% CI: 0.52-0.84) Grønbæk, et al 39 ACLF (as per EASL criteria) 185 Serum sCD163 3-month mortality AUC: 0.66 (0.59-0.73) Serum sMR AUC: (0.66 (0.59-0.72) ACLF: acute on chronic liver failure, APASL: Asia Pacific Association for Study of Liver, VWF: von Willebrand factor, AUC: Area under receiver operating curve, EASL: European Association for Study of Liver, sCD163: soluble CD163, sMR: soluble Mannose Receptor. a Composite poor outcome: Death/Liver transplant/Discharge in moribund state.…”
Section: Is the Liver An Immune Organ ( Table1 )?mentioning
confidence: 99%
See 1 more Smart Citation
“… Study Liver disease No. of patients Markers measured Outcome assessed Significance Vijayalekshmi, et al 54 Severe alcoholic hepatitis 50 Plasma VWF antigen 3-month mortality adjusted HR: 1.002 (95% CI: 1- 1.004) Tiwari, et al 55 Severe alcoholic hepatitis 34 Plasma VWF collagen binding activity In–hospital mortality (hospital stay: 6 days, median) AUC: 0.72 (95% CI: 0.54-0.89) Prasanna, et al 36 ACLF (as defined by APASL criteria) 50 Plasma VWF collagen binding activity In-hospital composite poor outcome a (hospital stay: 6 days, median) AUC: 0.68 (95% CI: 0.52-0.84) Grønbæk, et al 39 ACLF (as per EASL criteria) 185 Serum sCD163 3-month mortality AUC: 0.66 (0.59-0.73) Serum sMR AUC: (0.66 (0.59-0.72) ACLF: acute on chronic liver failure, APASL: Asia Pacific Association for Study of Liver, VWF: von Willebrand factor, AUC: Area under receiver operating curve, EASL: European Association for Study of Liver, sCD163: soluble CD163, sMR: soluble Mannose Receptor. a Composite poor outcome: Death/Liver transplant/Discharge in moribund state.…”
Section: Is the Liver An Immune Organ ( Table1 )?mentioning
confidence: 99%
“…Immune cells in peripheral blood: In hospitalized patients with cirrhosis and with ACLF, the ratio of neutrophils (innate immune cells) to lymphocytes (adaptive immune cells) - a marker of immune dysregulation - independently predicted 90-day mortality 53 , 54 .…”
Section: Indices Of Immune Activation In Cirrhosis and Aclf – Diagnostic Utility ( Table 2 )mentioning
confidence: 99%